An antibacterial peptide shows promise as an effective therapy against infections in wounds suffered by soldiers. Laszlo Otvos, a biologist at Temple's College of Science and Technology, and colleagues found that when given intramuscularly, the peptide A3-APO was more effective than current antimicrobial chemotherapy measures in treating multidrug-resistant Acinetobacter baumannii, the most common systemic infection found in soldiers who suffer burn or blast wounds. "This is the first peptide ever that is more efficacious in an animal model than anything else that is available," Otvos said. He hopes the peptide can be tested in clinical trials in the near future.